SCHEMBL6099640

SCHEMBL6099640

COc1cc(CC(=O)Nc2cccc(-c3ccc(F)cc3)c2)ccc1OCCN

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL9 O00512 6/20 0.58
CTNNB1 P35222 6/20 0.58
SMN1; SMN2 Q16637 8/20 0.54
LMNA P02545 4/20 0.54
HTT P42858 3/20 0.54
KMT2A Q03164 2/20 0.54
NPSR1 Q6W5P4 4/20 0.54
HSD17B10 Q99714 4/20 0.54
ALDH1A1 P00352 4/20 0.54
TSHR P16473 3/20 0.54
MAPK1 P28482 3/20 0.54
MAPT P10636 3/20 0.54
MEN1 O00255 1/20 0.54
TP53 P04637 2/20 0.54
FBP1 P09467 2/20 0.54
USP2 O75604 1/20 0.54
STAT3 P40763 2/20 0.53
HPGD P15428 3/20 0.52
XBP1 P17861 1/20 0.52
HTR1E P28566 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6099956 0.93 SMN1; SMN2 (0.55) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6100236 0.92 SMN1; SMN2 (0.54) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6101654 0.92 SMN1; SMN2 (0.63) SMN1; SMN2LMNAHTTKMT2ANPSR1
SCHEMBL6100605 0.91 SMN1; SMN2 (0.62) SMN1; SMN2LMNAHTTKMT2ANPSR1
Hydrochloric Acid SCHEMBL6099402 0.91 SMN1; SMN2 (0.62) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6100267 0.90 FBP1 (0.58) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6100220 0.90 SMN1; SMN2 (0.54) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6099067 0.88 SMN1; SMN2 (0.55) BCL9CTNNB1SMN1; SMN2LMNAHTT
SCHEMBL6102037 0.87 FBP1 (0.67) SMN1; SMN2LMNAHTTKMT2ANPSR1
SCHEMBL6100822 0.86 SMN1; SMN2 (0.57) SMN1; SMN2LMNAHTTKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084176-B2 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2006-08-01 US claimed
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-09 US claimed
EP-1403235-A1 N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Dainippon Pharmaceutical Co., Ltd. (JP) 2004-03-31 EP claimed
US-7084176-B2 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2006-08-01 US disclosed
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-09 US disclosed
EP-1403235-A1 N-ARYLPHENYLACETAMIDE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Dainippon Pharmaceutical Co., Ltd. (JP) 2004-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248983-A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same HRH2, CCR8, CYP2C8 BCL9 1496/4885CTNNB1 2228/4885SMN1; SMN2 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.